Researcher have developed a compound, P7C3-A20, which not only prevents mature neurons dying during stroke, but also encourages neurogenesis after a stroke to protect cognitive function.
Browsing: Cerebrovascular disease
Diagnosis of cSAH is challenging given its subtle findings, and management is empiric as there are only a few case series in literature – in this case report, Mao, Addess and Valsamis report a case of cortical subarachnoid hemorrhage (cSAH) and discuss its management
Research demonstrates that the onset of hypertension in later life is associated with a reduced risk of dementia after 90 years of age.
Lauren Pulling highlights some of the key trending topics in neurology and neuroscience from 2016, as well as the top read articles of the year – take a look and let us know your thoughts.
A reported case of nontraumatic cortical subarachnoid hemorrhage (cSAH) and discussion of diagnosis, treatment and management.
Population-based cohort study reports that increased serum NT-proBNP levels are associated with smaller brain volumes and could be used as a biomarker for disease such as stroke and dementia.
In this review the authors evaluate the safety and efficacy of cell therapies administered both acutely and sub-acutely after stroke.
A statement from the American Heart Association (Dallas, TX, USA) suggests that high blood pressure in middle age could lead to impaired cognition and may act as a risk factor for Alzheimer’s.
In this commentary, the author discusses the impact of the heart in embolic stroke with particular focus on atrial fibrillation and patent foramen ovale.